[Technical principles of prostatic cryosurgery (Part 1)].

Arch Esp Urol

Servicio de Urología, Hospital Ramón y Cajal, Carretera de Colmenar Km. 9,1, 28034 Madrid, España.

Published: December 2003

Objectives: Cryosurgery is defined as in situ freezing of tissues. Criosurgery in the treatment of prostate cancer aims to: 1- Eliminate all the glandular tissues and completely destroy the adenocarcinoma, 2- With a minimum number of complications. a) Preserving neighbour structures: bladder neck, striated sphincter, and rectum. b) Preserving urethral mucosa to reduce the elimination of sloughing tissues.

Methods: We describe the technique of prostatic cryosurgery including all innovations introduced during the last ten years. The map with the number and situation of the 6-8 crioprobes should be done in such a way that the iceball created around each of them overlaps the contiguous ones. Probe-mapping and icing strategy together get the prostate included in a unique, solid mass, in which temperature descents homogeneously and spreads out of its limits, so that intraprostatic and extraprostatic temperatures (sensors at the apex, Denonvilliers fascia and both neurovascular bundles) are below -40 degrees C.

Results: The standardized technique is based on: Substitution of liquid nitrogen by argon. Use of 6 to 8 cryoprobes. The probes are properly inserted into the perineum percutaneously under transrectal ultrasound guidance. Ice ball evolution control by biplane transrectal ultrasound. Separation of the two layers of Denonvilliers' fascia by injection of saline solution. Real-time measurement of temperature descent. Minimal temperature lower than -40 degrees C Commercial ureteral heating system. Double cycle of freezing-unfreezing Administration of hormonal therapy during time enough to avoid the gland size to exceed 45-50 cc.

Conclusions: We describe the most advanced technique for prostatic freezing, highlighting the basic requirements to achieve the objectives pursued. It has improved oncologic results, in relation to PSA and percentage of negative biopsies, and has dramatically reduced complications.

Download full-text PDF

Source

Publication Analysis

Top Keywords

prostatic cryosurgery
8
technique prostatic
8
-40 degrees
8
transrectal ultrasound
8
[technical principles
4
principles prostatic
4
cryosurgery objectives
4
objectives cryosurgery
4
cryosurgery defined
4
defined situ
4

Similar Publications

Introduction: Local disease recurrence following focal therapy (FT) for prostate cancer may be due to failure to eradicate focal disease or development of disease in the untreated prostate (in- and out-of-field recurrences). Several studies suggest in-field contrast enhancement (CE) on post-treatment multi-parametric (mp) MRI between 6-12 months following FT indicates residual disease. The present study assesses the incidence and oncologic implications of early CE observed following primary partial gland cryoablation (PPGCA).

View Article and Find Full Text PDF

Real-World Safety of Prostate Cancer Focal Therapy: MAUDE Database Analysis.

J Endourol

December 2024

Department of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

The aim of this study was to assess the real-world safety profile of medical devices used in focal prostate cancer treatment utilizing the Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database was searched for reports on high-intensity focused ultrasound (HIFU), cryoablation, laser ablation, and irreversible electroporation (IRE) devices used in prostate cancer treatment from 1993 to 2023. Adverse events were identified and categorized.

View Article and Find Full Text PDF

Cryotherapy versus radical prostatectomy as a salvage treatment for radio-recurrent prostate cancer.

World J Urol

September 2024

Department of Urology, Institut Mutualiste Montsouris, 42 boulevard Jourdan, Paris, 75014, France.

Introduction: The aim of this study is to compare outcomes of SRP (salvage radical prostatectomy) with SCAP (salvage cryoablation of the prostate) in local radio-recurrent PCa (prostate cancer) patients.

Materials And Methods: A retrospective analysis of a multicentric European Society of Uro-technology (ESUT) database was performed. Data on patients with local recurrent PCa after radiotherapy who underwent salvage treatment were collected.

View Article and Find Full Text PDF

Prostate cancer (PCa) is currently the second most common malignancy in men worldwide,and its incidence rate is on the rise. Most cases of PCa are treated by radical prostatectomy, but with the development of medical imaging and innovation in therapeutic theories and technology, focal therapy has shown better application prospects in the treatment of PCa. Compared with radical prostatectomy, focal therapy yields satisfactory results in terms of effectiveness and reduction of complications in addition to avoidance of overtreatment and treatment-related financial burden.

View Article and Find Full Text PDF

Combining cryoablation and immunotherapy presents a promising approach to revert immunosuppressive responses to solid tumors. However, challenges such as postablated residual tumors and insufficient immune activity contribute to recurrence after cryo-immunotherapy. Herein, we investigated metallic supra-structured cryo-nanocatalyst (MSCN), which features numerous ice nucleation sites and interspace loading of therapeutic agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!